Purchase Order 75N91022P00706
Award Date
7/29/22
Potential Completion Date
7/31/24
Potential Value
$723K
Federal Agency
National Cancer Institute
Awardee
Qiagen, LLC
Ultimate Awardee
Qiagen N.V.
PSC Category
Q301 - Reference Laboratory Testing
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Germantown, MD, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
1
Legislative Mandate
Service Contract Inventory
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This $467,900 firm fixed price purchase order was awarded by the National Cancer Institute (NCI), a component of the National Institutes of Health (NIH) within the Department of Health and Human Services (HHS), to Qiagen, LLC. The contract calls for Qiagen to provide clinical interpretation services for genomic variants identified through large next-generation gene panels, whole exome sequencing, and whole transcriptome sequencing conducted as part of NCI's Clinical Oncologic Molecular Pathology...
This is a firm fixed-price purchase order contract awarded by the Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Cancer Institute to Qiagen, LLC, a division of the international biotechnology company Qiagen N.V. The contract, valued at $15,641.00, is for the provision of genomic research and analysis tools, including DNA/RNA extraction kits, next-generation sequencing, digital PCR systems, sample preparation equipment, and bioinformatics software....
The Department of Health and Human Services National Institutes of Health National Cancer Institute awarded a $13,053 purchase order to Qiagen, LLC for service agreement work. Qiagen, a subsidiary of Qiagen N.V., will perform the services at its location in Bethesda, Maryland under the firm fixed price contract, which runs from September 1, 2023 through August 31, 2024. The award provides services to support the National Cancer Institute's research efforts as it works to prevent and cure cancer....
This is a firm-fixed-price purchase order awarded by the National Cancer Institute (NCI) to Qiagen, LLC to provide bioinformatics analysis services for next-generation sequencing (NGS) data used in the NCI-COMPASS precision cancer diagnostics program. Under the $786,438 contract, Qiagen will provide access to its QIAGEN Clinical Insight Interpret (QCII) bioinformatics platform to automatically classify and report on genomic variants in accordance with ACMG/AMP guidelines. The analysis will...
This federal contract award was issued by the National Cancer Institute (NCI), a civilian agency of the Department of Health and Human Services (HHS), to Qiagen, LLC, a division of the international biotechnology company Qiagen N.V. The $24,632.58 fixed-price contract with economic price adjustment is for a blanket purchase agreement (BPA) call order, with an ultimate completion date of July 3, 2018. Qiagen, which has provided products and services to support federal agencies' biomedical...
This is a firm fixed-price purchase order contract awarded by the Department of Health and Human Services' National Institutes of Health (NIH) National Cancer Institute to Qiagen, LLC, a division of the international biotechnology company Qiagen N.V. The $22,324.00 contract is for the provision of various products and services to support the NIH's biomedical research, public health, and healthcare programs, including DNA/RNA extraction kits, next-generation sequencing, digital PCR systems,...
This purchase order award from the Department of Health and Human Services' National Institutes of Health Clinical Center to Qiagen, LLC is for $10,847.20 to support library preparation in next generation sequencing assays for clinical center patients. Qiagen will provide products and services for DNA/RNA extraction and sample preparation to support the agency's biomedical research and public health programs. As an international provider of molecular diagnostics technologies, Qiagen has...
This federal contract award was made by the National Cancer Institute (NCI), a component of the U.S. Department of Health and Human Services, to Qiagen, LLC, a division of the international provider Qiagen N.V. The $4,060.08 firm fixed price contract is a Blanket Purchase Agreement (BPA) call order for the delivery of various products and services to support the NCI's biomedical research, public health, and healthcare programs. Based on Qiagen's capabilities, the contract likely involves the...
The Department of Health and Human Services National Institutes of Health National Cancer Institute awarded a $13,053 purchase order to Qiagen, LLC for maintenance agreement services. Qiagen, LLC is a division of Qiagen N.V., a global life sciences company, and will perform the services at its location in Bethesda, Maryland between August 2023 and August 2024 under firm fixed pricing. The award provides support for an existing Qiagen product or solution under a one-year period of performance...
This firm-fixed-price purchase order was awarded by the National Institutes of Health (NIH) Clinical Center to Qiagen, LLC, a division of Qiagen N.V., for $14,921.70. The contract is for library preparation items needed for next-generation sequencing assays for NIH Clinical Center patients. The order has a completion date of November 23, 2024. Qiagen is an international provider of sample and assay technologies that has previously provided DNA/RNA extraction kits, next-generation sequencing,...